BRIEF published on 07/31/2026 at 16:22, 1 month 11 days ago The Vanguard Group, Inc. Releases Disclosure on Rotork PLC Securities Form 8.3 Takeover Code Vanguard Group Rotork Plc
PRESS RELEASE published on 07/31/2026 at 16:22, 1 month 11 days ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle PLC The Vanguard Group, Inc. discloses a 4.75% stake in Tate & Lyle PLC through Form 8.3 filing, with 5.54 GBP per unit purchase price Form 8.3 Vanguard Group Stake Disclosure Tate & Lyle Plc GBP 5.54
BRIEF published on 07/31/2026 at 16:21, 1 month 11 days ago The Vanguard Group’s Stake in Prologis Inc. Disclosed Securities Takeover Code Vanguard Group Stake Disclosure Prologis Inc.
PRESS RELEASE published on 07/31/2026 at 16:21, 1 month 11 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC The Vanguard Group, Inc. discloses 3.55% ownership in Spire Healthcare Group PLC as of 30 July 2026 Vanguard Group Ownership Disclosure Public Disclosure Spire Healthcare Financial Holdings
BRIEF published on 07/31/2026 at 16:20, 1 month 11 days ago The Vanguard Group Discloses Interests in Picton Property Income Ltd Securities Takeover Code Vanguard Group Investment Disclosure Picton Property
BRIEF published on 07/31/2026 at 16:19, 1 month 11 days ago Vanguard Group Discloses Position in LondonMetric Property PLC Takeover Code Securities Disclosure Vanguard Group LondonMetric Property Schroder Real Estate
PRESS RELEASE published on 07/31/2026 at 16:19, 1 month 11 days ago Form 8.3 - The Vanguard Group, Inc.: Segro PLC The Vanguard Group, Inc. discloses 5.64% ownership in Segro PLC. Public disclosure under Rule 8.3 of Takeover Code The Vanguard Group Rule 8.3 Takeover Code Ownership Disclosure SEGRO PLC
BRIEF published on 07/31/2026 at 16:18, 1 month 11 days ago The Vanguard Group Inc. Discloses Position in JTC PLC Form 8.3 Takeover Code Securities Disclosure Vanguard Group JTC Plc
PRESS RELEASE published on 07/31/2026 at 16:18, 1 month 11 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders PLC The Vanguard Group, Inc. discloses a 2.71% stake in Schroders PLC through Form 8.3, with details of relevant securities and recent dealings Form 8.3 Securities Dealings Vanguard Group Inc. Schroders Plc Stake Disclosure
PRESS RELEASE published on 07/31/2026 at 16:17, 1 month 11 days ago Form 8.3 - The Vanguard Group, Inc.: Rotork PLC The Vanguard Group, Inc. discloses a 5.44% stake in Rotork PLC as of 30 July 2026. Details of their position disclosed in accordance with Rule 8.3 of the Takeover Code Rule 8.3 Takeover Code Vanguard Group Stake Disclosure Rotork Plc
Published on 09/12/2026 at 02:35, 3 hours 11 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 6 hours 46 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 7 hours 41 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 8 hours 21 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 12 hours 46 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 22:15, 7 hours 31 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 7 hours 36 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 10 hours 1 minute ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 11 hours 31 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 22 hours 46 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 22 hours 46 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 1 day 10 hours ago Availability of the 2026 Interim Financial Report
